Artificial Intelligence Sleep Chatbot in Emerging Black/African American Adults With Cardiometabolic Risk Factors: a Feasibility Study
Sponsor: University of Delaware
Trial Details
| Condition | Sleep Deprivation, Insomnia, Metabolic Syndrome |
| Intervention | sleep chatbot |
| Phase | NA |
| Status | Completed |
| Participants | 26 |
| Est. Completion | 5 Feb 2025 |
| Last Updated | 31 July 2026 |
Primary Outcome
Acceptability; Retention Rate; Insomnia Severity; PSQI; Total Sleep Time; Sleep Efficiency; Intra-individual Variability in Midsleep Times
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * male or female ages 18-25 years old * self-identified as Black/African Americans (BAA), * poor sleep \[Insomnia severity index (ISI) \>10\] * having at least one of the cardiometabolic risk factors on the Life's Essential 8 checklist for cardiovascular health, as defined by the American Heart Association, including health factors confirmed by fasting blood testing during the first lab visit (fasting blood glucose ≥110mg/dL, high-density lipoprotein (good cholesterol) ≤ 40 mg/dL for males and ≤ 50 mg/dL for females, triglycerides ≥150mg/dL, total cholesterol ≥200 mg/dL, blood pressure ≥130/85mmHg, waist circumference≥40 inches for males, ≥35 inches for females) or healthy behaviors such as short sleep (\<7 hours), smoking or inactive (\<150 minutes/week of moderate aerobic activity such as gardening, social dancing, or \< 75 minutes/week of vigorous aerobic activity such as running, swimming laps, jumping rope), and (e) own a smartphone (iPhone or Android). * own a smartphone (iPhone or Android). Exclusion Criteria: * self-report medical conditions \[i.e., major depressive disorder \[Patient Health Questionnaire-9 (PHQ-9) ≥15) * diagnosed obstructive apnea\] that may affect sleep * regular use of medications with substantial impact on sleep and cardio-metabolic markers * shift worker * smoker * alcohol abuse (Alcohol Use Disorders Identification Test--short form score ≥7 for males and ≥5 for females) * self-report pregnancy/lactation.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service